메뉴 건너뛰기




Volumn 62, Issue 4, 2019, Pages 298-302

Diabetes, heart failure, and renal dysfunction: The vicious circles

Author keywords

Cardiovascular disease; Chronic kidney disease; Diabetes mellitus; Diabetic kidney disease; Heart failure; Type 2 diabetes mellitus

Indexed keywords

CALCIUM;

EID: 85071341562     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2019.07.003     Document Type: Review
Times cited : (169)

References (44)
  • 1
    • 85061633193 scopus 로고    scopus 로고
    • Cardiovascular protection with anti-hyperglycemic agents
    • [in press]
    • Deedwania P, Acharya T. Cardiovascular protection with anti-hyperglycemic agents. Am J Cardiovasc Drugs 2019; in press
    • (2019) Am J Cardiovasc Drugs , vol.19 , pp. 249-257
    • Deedwania, P.1    Acharya, T.2
  • 2
    • 85046132173 scopus 로고    scopus 로고
    • Economic costs of diabetes in the U.S. in 2017
    • American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care 2018;41:917-928.
    • (2018) Diabetes Care , vol.41 , pp. 917-928
    • American Diabetes Association1
  • 3
    • 85045767187 scopus 로고    scopus 로고
    • Global economic burden of diabetes in adults: projections from 2015 to 2030
    • Bommer C, Sagaova V, Heesemann E et al. Global economic burden of diabetes in adults: Projections from 2015 to 2030. Diabetes Care 2018;41:963-970.
    • (2018) Diabetes Care , vol.41 , pp. 963-970
    • Bommer, C.1    Sagaova, V.2    Heesemann, E.3
  • 4
    • 84879202874 scopus 로고    scopus 로고
    • Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association
    • Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association. Circ Heart Fail 2013;6:606-619.
    • (2013) Circ Heart Fail , vol.6 , pp. 606-619
    • Heidenreich, P.A.1    Albert, N.M.2    Allen, L.A.3
  • 5
    • 85059500922 scopus 로고    scopus 로고
    • Heart failure in type 2 diabetes mellitus: impact of glucose-lowering agents, heart failure therapies, and novel therapeutic strategies
    • Kenny HC, Abel ED. Heart failure in type 2 diabetes mellitus: Impact of glucose-lowering agents, heart failure therapies, and novel therapeutic strategies. Circ Res 2019;124:121-141.
    • (2019) Circ Res , vol.124 , pp. 121-141
    • Kenny, H.C.1    Abel, E.D.2
  • 7
    • 84981201088 scopus 로고    scopus 로고
    • Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014
    • Afkarian M, ZelnickLR, Hall YN et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 2016;316:602-610.
    • (2016) JAMA , vol.316 , pp. 602-610
    • Afkarian, M.1    Zelnick, L.R.2    Hall, Y.N.3
  • 8
    • 0037108454 scopus 로고    scopus 로고
    • Age and the burden of death attributable to diabetes in the United States
    • Saydah SH, Eberhardt MS, Loria CM et al. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 2002;156:714-719.
    • (2002) Am J Epidemiol , vol.156 , pp. 714-719
    • Saydah, S.H.1    Eberhardt, M.S.2    Loria, C.M.3
  • 9
    • 85047497547 scopus 로고    scopus 로고
    • Risk of incident heart failure in patients with diabetes and asymptomatic left ventricular systolic dysfunction
    • Rorth R, Jhundi PS, Mogensen UM et al. Risk of incident heart failure in patients with diabetes and asymptomatic left ventricular systolic dysfunction. Diabetes Care 2018;41:1285-1291.
    • (2018) Diabetes Care , vol.41 , pp. 1285-1291
    • Rorth, R.1    Jhundi, P.S.2    Mogensen, U.M.3
  • 10
    • 85046398177 scopus 로고    scopus 로고
    • Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
    • Seferovic PM, Petrie MC, Filippatos GS et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J. Heart Fail 2018;20:853-872.
    • (2018) Eur J Heart Fail , vol.20 , pp. 853-872
    • Seferovic, P.M.1    Petrie, M.C.2    Filippatos, G.S.3
  • 11
    • 85062154232 scopus 로고    scopus 로고
    • Heart disease and stroke statistics – 2019 update: a report from the American Heart Association
    • Benjamin EJ, Muntner P, Alonso A et al. Heart disease and stroke statistics – 2019 update: A report from the American Heart Association. Circulation 2019;139:e56-e528.
    • (2019) Circulation , vol.139 , pp. e56-e528
    • Benjamin, E.J.1    Muntner, P.2    Alonso, A.3
  • 12
    • 84988458382 scopus 로고    scopus 로고
    • Temporal trends and factors associated with diabetes mellitus among patient hospitalized with heart failure: findings from get with the guidelines – heart failure registry
    • Echouffo-Tcheugui JB, Xu H, DeVore AD et al. Temporal trends and factors associated with diabetes mellitus among patient hospitalized with heart failure: Findings from Get With the Guidelines – Heart Failure registry. Am Heart J 2016;182:9-20.
    • (2016) Am Heart J , vol.182 , pp. 9-20
    • Echouffo-Tcheugui, J.B.1    Xu, H.2    DeVore, A.D.3
  • 13
    • 0037356757 scopus 로고    scopus 로고
    • Higher incidence of new-onset diabetes in patients with heart failure
    • Grundy SM. Higher incidence of new-onset diabetes in patients with heart failure. Am J Med 2003;114:331-332.
    • (2003) Am J Med , vol.114 , pp. 331-332
    • Grundy, S.M.1
  • 14
    • 0037353460 scopus 로고    scopus 로고
    • Functional class in patients with heart failure is associated with the development of diabetes
    • Tenenbaum A, Motro M, Fishman EZ et al. Functional class in patients with heart failure is associated with the development of diabetes. Am J Med 2003;114:271-275.
    • (2003) Am J Med , vol.114 , pp. 271-275
    • Tenenbaum, A.1    Motro, M.2    Fishman, E.Z.3
  • 15
    • 79551494642 scopus 로고    scopus 로고
    • Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices
    • Uriel N, Naka Y, Colombo PC et al. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices. Eur J Heart Fail 2011;13:195-199.
    • (2011) Eur J Heart Fail , vol.13 , pp. 195-199
    • Uriel, N.1    Naka, Y.2    Colombo, P.C.3
  • 16
    • 85064646839 scopus 로고    scopus 로고
    • Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies
    • Rangaswami J, Bhalla V, Blair JEA et al. Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies. Circulation 2019;139:e840-878.
    • (2019) Circulation , vol.139 , pp. e840-e878
    • Rangaswami, J.1    Bhalla, V.2    Blair, J.E.A.3
  • 17
    • 85056655699 scopus 로고    scopus 로고
    • Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association – European Society of Cardiology
    • Maack C, Lehrke M, Backs J et al. Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association – European Society of Cardiology. Eur Heart J 2018;39:4243-4254.
    • (2018) Eur Heart J , vol.39 , pp. 4243-4254
    • Maack, C.1    Lehrke, M.2    Backs, J.3
  • 18
    • 84872532310 scopus 로고    scopus 로고
    • Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta analysis
    • Ergou S, et al. Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta analysis. Eur J Heart Fail. 2013;15:185-193.
    • (2013) Eur J Heart Fail , vol.15 , pp. 185-193
    • Ergou, S.1
  • 19
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (ukpds 35): prospective observational study
    • Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (ukpds 35): Prospective observational study. BMJ 2000;321:405-412.
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.3
  • 20
    • 85132189046 scopus 로고    scopus 로고
    • Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
    • Lee R, Wong TY, Sabanayagam C et al. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye and Vision 2015;2:17
    • (2015) Eye and Vision , vol.2 , pp. 17
    • Lee, R.1    Wong, T.Y.2    Sabanayagam, C.3
  • 21
    • 85038937860 scopus 로고    scopus 로고
    • The prognostic significance of diabetes and microvascular complications in patients with heart failure with preserved ejection fraction
    • Sandesara PB, O'’Neal WT, Kelli HM et al. The prognostic significance of diabetes and microvascular complications in patients with heart failure with preserved ejection fraction. Diabetes Care 2018;41:150-155.
    • (2018) Diabetes Care , vol.41 , pp. 150-155
    • Sandesara, P.B.1    O'Neal, W.T.2    Kelli, H.M.3
  • 22
    • 85065843781 scopus 로고    scopus 로고
    • Influence of microvascular disease on cardiovascular events in type 2 diabetes
    • Verma S, Wanner C, Zweiner I et al. Influence of microvascular disease on cardiovascular events in type 2 diabetes. J Am Coll Cardiol 2019;73:2780-2782.
    • (2019) J Am Coll Cardiol , vol.73 , pp. 2780-2782
    • Verma, S.1    Wanner, C.2    Zweiner, I.3
  • 23
    • 84862008999 scopus 로고    scopus 로고
    • Lipid metabolism and toxicity in the heart
    • Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab. 2012;15:805-812.
    • (2012) Cell Metab , vol.15 , pp. 805-812
    • Goldberg, I.J.1    Trent, C.M.2    Schulze, P.C.3
  • 24
    • 84896092380 scopus 로고    scopus 로고
    • Molecular mechanisms of diabetic cardiomyopathy
    • Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 2014;57:660-671.
    • (2014) Diabetologia , vol.57 , pp. 660-671
    • Bugger, H.1    Abel, E.D.2
  • 25
    • 85019634930 scopus 로고    scopus 로고
    • An overview of the inflammatory signaling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy
    • Frati, G. An overview of the inflammatory signaling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovascular Res. 2017; 113:378-388.
    • (2017) Cardiovasc Res , vol.113 , pp. 378-388
    • Frati, G.1
  • 26
    • 44949172981 scopus 로고    scopus 로고
    • Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme
    • MacDonald MR, Petrie MC, Varyani F et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J 2008;29:1377-1385.
    • (2008) Eur Heart J , vol.29 , pp. 1377-1385
    • MacDonald, M.R.1    Petrie, M.C.2    Varyani, F.3
  • 27
    • 0034739458 scopus 로고    scopus 로고
    • Coronary composition and macrophage infiltration in atherectomy specimens from patient with diabetes mellitus
    • Moreno PR, Murcia AM, Palacios IF et al. Coronary composition and macrophage infiltration in atherectomy specimens from patient with diabetes mellitus. Circulation 2000;102:2180-2184.
    • (2000) Circulation , vol.102 , pp. 2180-2184
    • Moreno, P.R.1    Murcia, A.M.2    Palacios, I.F.3
  • 28
    • 49649090453 scopus 로고    scopus 로고
    • Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome
    • Undas A, Wiek I, Stepien E, Zmudka K, Tracz W. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care. 2008;31:1590-1595.
    • (2008) Diabetes Care , vol.31 , pp. 1590-1595
    • Undas, A.1    Wiek, I.2    Stepien, E.3    Zmudka, K.4    Tracz, W.5
  • 29
  • 31
    • 84937227669 scopus 로고    scopus 로고
    • Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
    • Seferovic PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J. 2015;36:1718-1727.
    • (2015) Eur Heart J , vol.36 , pp. 1718-1727
    • Seferovic, P.M.1    Paulus, W.J.2
  • 32
    • 85064836178 scopus 로고    scopus 로고
    • Diabetic cardiomyopathy: what is it and can it be fixed?
    • Dillmann WH. Diabetic cardiomyopathy: What is it and can it be fixed? Circ Res 2019;124:1160-1162.
    • (2019) Circ Res , vol.124 , pp. 1160-1162
    • Dillmann, W.H.1
  • 33
    • 0015498586 scopus 로고
    • New type of cardiomyopathy associated with diabetic glomerulosclerosis
    • Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;30:595-602.
    • (1972) Am J Cardiol , vol.30 , pp. 595-602
    • Rubler, S.1    Dlugash, J.2    Yuceoglu, Y.Z.3
  • 34
    • 84873359828 scopus 로고    scopus 로고
    • Kidney disease and increased mortality risk in type 2 diabetes
    • Afkarian M, Sachs MC, Kestenbaum B et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013;24:302-308.
    • (2013) J Am Soc Nephrol , vol.24 , pp. 302-308
    • Afkarian, M.1    Sachs, M.C.2    Kestenbaum, B.3
  • 35
    • 85049363563 scopus 로고    scopus 로고
    • Pathology identifies glomerular treatment targets in diabetic nephropathy
    • Alpers CE, Hudkins KL. Pathology identifies glomerular treatment targets in diabetic nephropathy. Kidney Res Clin Pract 2018;37:106-111.
    • (2018) Kidney Res Clin Pract , vol.37 , pp. 106-111
    • Alpers, C.E.1    Hudkins, K.L.2
  • 36
    • 85064005750 scopus 로고    scopus 로고
    • Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity
    • [epublished April 4]
    • Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M. Consequences of glomerular hyperfiltration: The role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity. Nephron 2019; epublished April 4
    • (2019) Nephron
    • Chagnac, A.1    Zingerman, B.2    Rozen-Zvi, B.3    Herman-Edelstein, M.4
  • 37
    • 84928743782 scopus 로고    scopus 로고
    • Uric acid as a biomarker and a therapeutic target in diabetes
    • Lytvyn Y, Perkins BA, Cherney DZI. Uric acid as a biomarker and a therapeutic target in diabetes. Can J Diabetes 2015;39:239-246.
    • (2015) Can J Diabetes , vol.39 , pp. 239-246
    • Lytvyn, Y.1    Perkins, B.A.2    Cherney, D.Z.I.3
  • 38
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998;352:837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
    • UK Prospective Diabetes Study (UKPDS) Group1
  • 39
    • 0034641550 scopus 로고    scopus 로고
    • Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
    • Adler AI, Stratton IM, Yudkin JS et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-419.
    • (2000) BMJ , vol.321 , pp. 412-419
    • Adler, A.I.1    Stratton, I.M.2    Yudkin, J.S.3
  • 40
    • 85017341929 scopus 로고    scopus 로고
    • Evolocumab and clinical outcomes in patients with cardiovascular disease
    • Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017;376:1713-1722.
    • (2017) N Engl J Med , vol.376 , pp. 1713-1722
    • Sabatine, M.S.1    Giugliano, R.P.2    Keech, A.C.3
  • 41
    • 84907087561 scopus 로고    scopus 로고
    • Angiotensin-neprilysin inhibition versus enalapril in heart failure
    • McMurray JJ, Packer M, Desai AS et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993-1004.
    • (2014) N Engl J Med , vol.371 , pp. 993-1004
    • McMurray, J.J.1    Packer, M.2    Desai, A.S.3
  • 42
    • 85061124164 scopus 로고    scopus 로고
    • Angiotensin-neprilysin inhibition in acute decompensated heart failure
    • Velazquez EJ, Morrow DA, DeVore AD et al. Angiotensin-neprilysin inhibition in acute decompensated heart failure. N Engl J Med 2019;380:539-548.
    • (2019) N Engl J Med , vol.380 , pp. 539-548
    • Velazquez, E.J.1    Morrow, D.A.2    DeVore, A.D.3
  • 43
    • 85060260357 scopus 로고    scopus 로고
    • Sodium-glucose cotransporter 2 inhibition and diabetic kidney disease
    • Alcic RZ, Neumiller JJ, Johnson EJ et al. Sodium-glucose cotransporter 2 inhibition and diabetic kidney disease. Diabetes 2019;68:248-257.
    • (2019) Diabetes , vol.68 , pp. 248-257
    • Alcic, R.Z.1    Neumiller, J.J.2    Johnson, E.J.3
  • 44
    • 85058733652 scopus 로고    scopus 로고
    • Standards of medical Care in Diabetes – 2019
    • Summary of revisions: Standards of Medical Care in Diabetes – 2019. Diabetes Care 2019;42(Suppl 1):S4-S6.
    • (2019) Diabetes Care , vol.42 , pp. S4-S6
    • Summary of revisions1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.